From: Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
Cost-effectiviness analysis with the three different estimated 'recourse to malaria chemoprophylaxis' | 55% | 68.70% | 82.40% | |||
---|---|---|---|---|---|---|
Current situation of no reimbursement | 80% reimbursement strategy | Current situation of no reimbursement | 80% reimbursement strategy | Current situation of no reimbursement | 80% reimbursement strategy | |
Cost per journey (€) (95% CI) | 65.45 (47.88 - 86.03) | 50.94 (41.25 - 62.36) | 50.05 (36.76 - 65.50) | 45.36 (37.38 - 54.96) | 36.64 (25.49 - 45.46) | 39.78 (33.42 - 47.74) |
Effect per journey (%) (95% CI) = probabilty of contracting malaria | 0.01196 (0.00861 - 0.01587) | 0.00625 (0.00445 -0.00836) | 0.00891 (0.00640 - 0.01184) | 0.00494 (0.00348 - 0.00669) | 0.00586 (0.00417 - 0.00786) | 0.00363 (0.00249 - 0.00506) |
Cost Effectiveness ratio (€) | ||||||
Per case of malaria prevented | - | 8'151 | - | 9'186 | - | 10'969 |
Per malaria related death prevented | - | 679'250 | - | 765'490 | - | 914'045 |
Incremental cost (€) of 80% reimbursement strategy | ||||||
Per additional malaria case prevented | Reference strategy | dominant | Reference strategy | dominant | Reference strategy | 2'302 |
Per additional malaria related death prevented | Reference strategy | dominant | Reference strategy | dominant | Reference strategy | 191'833 |